Literature DB >> 30592630

Glutamyl-prolyl-tRNA synthetase induces fibrotic extracellular matrix via both transcriptional and translational mechanisms.

Dae-Geun Song1,2, Doyeun Kim3, Jae Woo Jung4, Seo Hee Nam1, Ji Eon Kim1, Hye-Jin Kim1, Jong Hyun Kim3, Seo-Jin Lee5, Cheol-Ho Pan2, Sunghoon Kim3, Jung Weon Lee1,3,4.   

Abstract

Fibrosis is characterized by the increased accumulation of extracellular matrix (ECM), which drives abnormal cell proliferation and progressive organ dysfunction in many inflammatory and metabolic diseases. Studies have shown that halofuginone, a racemic halogenated derivative, inhibits glutamyl-prolyl-transfer RNA-synthetase (EPRS)-mediated fibrosis. However, the mechanism by which this occurs is unclear. We explored the mechanistic aspects of how EPRS could develop liver fibrotic phenotypes in cells and animal models. Treatment with TGF-β1 up-regulated fibronectin and collagen I levels in LX2 hepatic stellate cells. This effect was inhibited in prolyl-transfer RNA synthetase (PRS)-suppressed LX2 cells. Using the promoter luciferase assay, TGF-β1-mediated collagen I, α1 chain transcription and γ2 basal laminin transcription in LX2 cells were down-regulated by EPRS suppression, suggesting that EPRS may play roles in ECM production at transcriptional levels. Furthermore, signal transducer and activator of transcription (STAT) signaling activation was involved in the effects of TGF-β1 on ECM expression in a PRS-dependent manner. This was mediated via a protein-protein complex formation consisting of TGF-β1 receptor, EPRS, Janus kinases, and STAT6. Additionally, ECM expression in fibrotic livers overlapped with EPRS expression along fibrotic septa regions and was positively correlated with STAT6 activation in carbon tetrachloride-treated mice. This was less obvious in livers of Eprs-/+ mice. These findings suggest that, during fibrosis development, EPRS plays roles in nontranslational processes of ECM expression via intracellular signaling regulation upon TGF-β1 stimulation.-Song, D.-G., Kim, D., Jung, J. W., Nam, S. H., Kim, J. E., Kim, H.-J., Kim, J. H., Lee, S.-J., Pan, C.-H., Kim, S., Lee, J. W. Glutamyl-prolyl-tRNA synthetase induces fibrotic extracellular matrix via both transcriptional and translational mechanisms.

Entities:  

Keywords:  STAT6; fibrotic animal model; hepatic stellate cells; prolyl-tRNA-synthetase; signal transduction

Year:  2018        PMID: 30592630     DOI: 10.1096/fj.201801344RR

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  6 in total

1.  Aminoacyl-tRNA synthetase inhibition activates a pathway that branches from the canonical amino acid response in mammalian cells.

Authors:  Yeonjin Kim; Mark S Sundrud; Changqian Zhou; Maja Edenius; Davide Zocco; Kristen Powers; Miao Zhang; Ralph Mazitschek; Anjana Rao; Chang-Yeol Yeo; Erika H Noss; Michael B Brenner; Malcolm Whitman; Tracy L Keller
Journal:  Proc Natl Acad Sci U S A       Date:  2020-04-06       Impact factor: 11.205

2.  Hepatoprotective effect and possible mechanism of phytoestrogen calycosin on carbon tetrachloride-induced liver fibrosis in mice.

Authors:  Mengmeng Zhang; Yaxin Wang; Guannan Zhu; Cheng Sun; Jiajia Wang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-05-30       Impact factor: 3.000

3.  Glutamyl-Prolyl-tRNA Synthetase Regulates Proline-Rich Pro-Fibrotic Protein Synthesis During Cardiac Fibrosis.

Authors:  Jiangbin Wu; Kadiam C Venkata Subbaiah; Li Huitong Xie; Feng Jiang; Eng-Soon Khor; Deanne Mickelsen; Jason R Myers; Wai Hong Wilson Tang; Peng Yao
Journal:  Circ Res       Date:  2020-07-01       Impact factor: 17.367

4.  TM4SF5-mediated liver malignancy involves NK cell exhaustion-like phenotypes.

Authors:  Hyunseung Sun; Eunmi Kim; Jihye Ryu; Hyejin Lee; Eun-Ae Shin; Minhyeong Lee; Haesong Lee; Jeong-Hoon Lee; Jung-Hwan Yoon; Dae-Geun Song; Semi Kim; Jung Weon Lee
Journal:  Cell Mol Life Sci       Date:  2021-12-18       Impact factor: 9.261

5.  Hepatocyte-specific Prominin-1 protects against liver injury-induced fibrosis by stabilizing SMAD7.

Authors:  Hyun Lee; Dong-Min Yu; Myeong-Suk Bahn; Young-Jae Kwon; Min Jee Um; Seo Yeon Yoon; Ki-Tae Kim; Myoung-Woo Lee; Sung-Je Jo; Sungsoo Lee; Seung-Hoi Koo; Ki Hoon Jung; Jae-Seon Lee; Young-Gyu Ko
Journal:  Exp Mol Med       Date:  2022-08-29       Impact factor: 12.153

Review 6.  The pathophyiological role of aminoacyl-tRNA synthetases in digestive system diseases.

Authors:  Wugelanmu Wusiman; Zerui Zhang; Qiang Ding; Mei Liu
Journal:  Front Physiol       Date:  2022-08-09       Impact factor: 4.755

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.